Evaluating migraine treatment designs
Part of Brain & nervous system, Pain clinical trials.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You have had migraine (with or without aura) for at least one year, and it was diagnosed before age 50.
- You have 2 to 8 migraine days per month (episodic migraine).
- You have used triptans (migraine rescue medicines) before or currently.
- You can speak and read Danish (the study is conducted in Denmark).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This trial tests two new migraine medicines, rimegepant and zavegepant, given to people in the emergency department to see how well they work for stopping a migraine headache quickly.
This trial tests a mobile app called Health enSuite Migraine to help manage migraines. You'll track your headaches daily for a month, then use the app to see if it reduces your migraine days.
This trial tests a type of acupuncture called Fu's Subcutaneous Needling (FSN) to see if it helps people with migraine without aura. It compares FSN to a common migraine prevention medication to find out which works better and why.
This Phase 3 trial tests tizanidine to help prevent migraine attacks. If you have frequent migraine with or without aura, it compares tizanidine against placebo while tracking your headaches in diaries.
Hear when a new Migraine With Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.